ZH4-74110-07190
3 vaccinations
2 coded responses
27 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 080 / NJ
- Registered
- 2021-01-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-01-31
Registered in v-safe
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-02-05
- 2021-02-06
-
2021-02-17
Survey response — day 14, dose 1MedDRA: Cough, Nasal congestion, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Sore throat, stuffy nose, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Dose 2 — Pfizer-BioNTech
- 2021-02-20
-
2021-02-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-03-20
- 2021-03-29
- 2021-04-03
- 2021-05-22
- 2021-08-23
-
2021-12-10
Dose 3 — Pfizer-BioNTech
- 2022-02-20
- 2022-03-13
-
2022-06-10
Survey response — 6 months, dose 3MedDRA: Vitiligo — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: VitiligoMedDRA releases: 2024-11 · check-in free text available
-
2022-06-10
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-06-13
- 2022-12-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-12-10 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-10 | Unsuccessful |
Free text
Release 4 — day 14, dose 1
Symptoms: Sore throat, stuffy nose, cough
Release 12 — 6 months, dose 3
Symptoms: Vitiligo
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Vitiligo | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release